Baird Medical Investment Holdings Limited
BDMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $37 | $31 | $35 | $28 |
| % Growth | 17.7% | -10.4% | 26.6% | – |
| Cost of Goods Sold | $4 | $4 | $7 | $5 |
| Gross Profit | $33 | $27 | $28 | $23 |
| % Margin | 88.2% | 86.6% | 79.9% | 83.6% |
| R&D Expenses | $6 | $4 | $4 | $1 |
| G&A Expenses | $6 | $9 | $7 | $7 |
| SG&A Expenses | $10 | $11 | $11 | $10 |
| Sales & Mktg Exp. | $4 | $3 | $4 | $4 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $17 | $15 | $13 | $10 |
| Operating Income | $15 | $12 | $14 | $12 |
| % Margin | 41.4% | 37.7% | 38.8% | 43% |
| Other Income/Exp. Net | -$1 | $0 | $1 | $1 |
| Pre-Tax Income | $14 | $12 | $15 | $13 |
| Tax Expense | $1 | $2 | $2 | $2 |
| Net Income | $12 | $11 | $13 | $12 |
| % Margin | 33.6% | 33.5% | 35.8% | 42.1% |
| EPS | 0.49 | 0.41 | 0.022 | -0.024 |
| % Growth | 19.5% | 1,789.4% | 189.7% | – |
| EPS Diluted | 0.49 | 0.41 | 0.022 | -0.024 |
| Weighted Avg Shares Out | 26 | 8 | 6 | 7 |
| Weighted Avg Shares Out Dil | 26 | 8 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $1 | $1 | $1 |
| EBITDA | $16 | $13 | $16 | $14 |
| % Margin | 43.7% | 40.9% | 46.4% | 51.1% |